US Stock MarketDetailed Quotes

INTS Intensity Therapeutics

Watchlist
  • 3.925
  • 0.0000.00%
Close Apr 26 16:00 ET
53.81MMarket Cap-4537P/E (TTM)

Intensity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intensity Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.23

+46.14%
Analyst Rating

No Data

Intensity Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--

Intensity Therapeutics Earnings Reports

  • Intensity Therapeutics | 10-K: Annual report

    Mar 14 16:06 ET

  • Intensity Therapeutics | 10-Q: Quarterly report

    Nov 13, 2023 12:10 ET

  • Intensity Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Aug 14, 2023 17:25 ET

  • Intensity Therapeutics | 10-Q: Quarterly report

    Aug 14, 2023 12:45 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg